Skip to main content

Developing Physician-Sponsored Investigational Device Exemption Protocols

  • Chapter
  • First Online:
  • 2646 Accesses

Abstract

The practice of device modification is legal and unregulated by the United States government in most instances. However, the U.S. Food and Drug Administration (FDA) has wide and unlimited authority to intervene when patient safety or effectiveness of the device becomes a concern. The Center for Medicare and Medicaid Services (CMS), depending on the regional carrier, may choose to fully compensate or pay absolutely nothing for these cases based on an assessment of “investigational use.” Any practitioner who chooses to modify an existing FDA-approved medical device outside of an approved Investigational Device Exemption (IDE) clinical trial should weigh heavily the ramifications of a product liability claim and/or a criminal or civil liability claim, as the manufacturer becomes exempt once the device has been modified. It is the author’s opinion that physicians performing device modification of the nature described herein are obliged to obtain an IDE.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Uflacker R, Robison JD, Schonholz C, Ivancev K. Clinical experience with a customized fenestrated endograft for juxtarenal abdominal aortic aneurysm repair. J Vasc Interv Radiol. 2006;17:1935–42.

    Article  PubMed  Google Scholar 

  2. Starnes BW. Physician-modified endovascular grafts for the treatment of elective, symptomatic, or ruptured juxtarenal aortic aneurysms. J Vasc Surg. 2012;56:601–7.

    Article  PubMed  Google Scholar 

  3. Food and Drug Administration Modernization Act of 1997. The National Academies. 161. Accessed 18 Aug 2012.

    Google Scholar 

  4. Gee T. Impact of modifying FDA regulated devices. http://medicalconnectivity.com/2009/10/25/impact-of-modifying-fda-regulated-devices. Accessed 25 Oct 2009.

  5. Brown OW. Legal implications of pushing the endovascular envelope. J Vasc Surg. 2012;56:273–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Benjamin W. Starnes .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Mayo Foundation for Medical Education and Research

About this chapter

Cite this chapter

Starnes, B.W. (2017). Developing Physician-Sponsored Investigational Device Exemption Protocols. In: Oderich, G. (eds) Endovascular Aortic Repair. Springer, Cham. https://doi.org/10.1007/978-3-319-15192-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15192-2_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15191-5

  • Online ISBN: 978-3-319-15192-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics